Adolescents and young adults are increasingly using GLP-1 receptor agonists for weight management, raising concerns among ...

The PIL seeks a ban on the marketing and distribution of specific GLP-1 receptor agonist (RA) drugs, namely Semaglutide, ...

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

In the same way weight varies from person to person, so do the best weight loss strategies. While some people succeed with ...

Discover a recent report that states that, although GLP-1 medicines are generally well tolerated, there have been cases of ...

UK health authorities are investigating pancreatitis cases linked to weight-loss drugs like Ozempic and Mounjaro. We spoke to ...

The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by rising obesity and type 2 diabetes incidences, the ...

The Delhi High Court on Tuesday disposed of a public interest litigation (PIL) raising alarm over the off-label and ...

While real-time data on how Indians are responding to these drugs is still emerging, experts say that sustained weight loss ...

China has approved a new weight-loss drug that is poised to rival Novo Nordisk and Eli Lilly's popular GLP-1 treatments, ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

California lawmakers introduced bills to increase doctors' menopause training. ( NPR) The majority of people in the U.S. who ...